Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Survivorship
Published in: Journal of Cancer Survivorship 3/2012

01-09-2012

Persistent cigarette smoking and other tobacco use after a tobacco-related cancer diagnosis

Authors: J. Michael Underwood, Julie S. Townsend, Eric Tai, Arica White, Shane P. Davis, Temeika L. Fairley

Published in: Journal of Cancer Survivorship | Issue 3/2012

Login to get access

Abstract

Introduction

People who continue to smoke after a cancer diagnosis have an increased risk for recurrences or development of new malignancies. These risks may be even higher among tobacco-related cancer survivors (TRCS). We describe tobacco use behaviors among TRCS, other cancer survivors, and people without a history of cancer.

Methods

We used 2009 Behavioral Risk Factor Surveillance System data to describe demographic characteristics, smoking history, current smoking prevalence, and smokeless tobacco use among TRCS, other cancer survivors, and people without a history of cancer (cigarette smoking and smokeless tobacco use were calculated after adjusting for age, sex, race, and insurance status). Tobacco-related cancers were defined as lung/bronchial, pharyngeal, laryngeal, esophageal, stomach, pancreatic, kidney/renal, urinary bladder, cervical, and acute myeloid leukemia.

Results

A total of 20 % of all cancer survivors were TRCS. TRCS were primarily female (68 %) and white (78 %). Smoking prevalence was higher among TRCS (27 %) compared with other cancer survivors (16 %) and respondents without a history of cancer (18 %). Smokeless tobacco use was higher among respondents without a history of cancer (4 %) compared with TRCS (3 %) and other cancer survivors (3 %).

Conclusions

The self-reported smoking prevalence among TRCS is higher than among other cancer survivors and people without a history of cancer. Targeted smoking prevention and cessation interventions are needed for cancer survivors, especially those diagnosed with a tobacco-related cancer.

Implications for cancer survivors

We recommend all cancer survivors be made aware of the health risks associated with smoking after a cancer diagnosis, and smoking cessation services be offered to those who currently smoke.

Condensed abstract

We provide the first population-based report on demographic characteristics and tobacco use behaviors among self-reported tobacco-related cancer survivors.
Literature
1.
Centers for Disease Control and Prevention. [Cancer Survivors—United States, 2007]. MMWR Morb Mortal Wkly Rep 2011;60:269–272.
2.
Fairley TL, Pollack LA, Moore AR, Smith JL. Addressing cancer survivorship through public health: an update from the Centers for Disease Control and Prevention. J Womens Health (Larchmt). 2009;18(10):1525–31.CrossRef
3.
Coups EJ, Ostroff JS. A population-based estimate of the prevalence of behavioral risk factors among adult cancer survivors and noncancer controls. Prev Med. 2005;40(6):702–11.PubMedCrossRef
4.
Mariotto AB, Robin Yabroff K, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst. 2011;103(2):117.PubMedCrossRef
5.
Pollack LA, Rowland JH, Crammer C, Stefanek M. Introduction: charting the landscape of cancer survivors' health-related outcomes and care. Cancer. 2009;115(18 Suppl):4265–9.PubMedCrossRef
6.
Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Committee on Cancer Survivorship: Improving Care and Quality of Life. Washington: National Academies Press; 2006.
7.
Centers for Disease Control and Prevention: annual smoking attributable mortality, years of potential life lost, and economic costs. United States 1995–1999. MMWR Morb Mortal Wkly Rep. 2004;Centers for Disease Control and Prevention.
8.
The 2004 United States Surgeon General's Report: the health consequences of smoking. NSW Public Health Bull. 2004;15(5–6):107.
9.
Stewart SL, Cardinez CJ, Richardson LC, et al. Surveillance for cancers associated with tobacco use—United States, 1999–2004. MMWR Surveill Summ. 2008;57(8):1–33.PubMed
10.
Klosky JL, Tyc VL, Garces-Webb DM, Buscemi J, Klesges RC, Hudson MM. Emerging issues in smoking among adolescent and adult cancer survivors: a comprehensive review. Cancer. 2007;110(11):2408–19.PubMedCrossRef
11.
Mackenbach JP, Borsboom GJ, Nusselder WJ, Looman CW, Schrijvers CT. Determinants of levels and changes of physical functioning in chronically ill persons: results from the GLOBE Study. J Epidemiol Community Health. 2001;55(9):631–8.PubMedCrossRef
12.
Richardson GE, Tucker MA, Venzon DJ, Linnoila RI, Phelps R, Phares JC, et al. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med. 1993;119(5):383–90.PubMed
13.
Emmons K, Li FP, Whitton J, Mertens AC, Hutchinson R, Diller L, et al. Predictors of smoking initiation and cessation among childhood cancer survivors: a report from the childhood cancer survivor study. J Clin Oncol. 2002;20(6):1608–16.PubMedCrossRef
14.
Mulhern RK, Tyc VL, Phipps S, Crom D, Barclay D, Greenwald C, et al. Health-related behaviors of survivors of childhood cancer. Med Pediatr Oncol. 1995;25(3):159–65.PubMedCrossRef
15.
Tyc VL, Klosky JL, Lensing S, Throckmorton-Belzer L, Rai SN. A comparison of tobacco-related risk factors between preadolescents with and without cancer. J Cancer Surviv. 2009;3(4):251–9.PubMedCrossRef
16.
Emmons KM, Butterfield RM, Puleo E, Park ER, Mertens A, Gritz ER, et al. Smoking among participants in the childhood cancer survivors cohort: the partnership for health study. J Clin Oncol. 2003;21(2):189–96.PubMedCrossRef
17.
Cox LS, Africano NL, Tercyak KP, Taylor KL. Nicotine dependence treatment for patients with cancer. Cancer. 2003;98(3):632–44.PubMedCrossRef
18.
Fairley TL, Hawk H, Pierre S. Health behaviors and quality of life of cancer survivors in Massachusetts, 2006: data use for comprehensive cancer control. Prev Chronic Dis. 2010;7(1):A09.PubMedCrossRef
19.
Johnston-Early A, Cohen MH, Minna JD, Paxton LM, Fossieck Jr BE, Ihde DC, et al. Smoking abstinence and small cell lung cancer survival. An association. JAMA. 1980;244(19):2175–9.PubMedCrossRef
20.
Garces YI, Yang P, Parkinson J, Zhao X, Wampfler JA, Ebbert JO, et al. The relationship between cigarette smoking and quality of life after lung cancer diagnosis. Chest. 2004;126(6):1733–41.PubMedCrossRef
21.
Tao ML, Guo MD, Weiss R, Byrne J, Mills JL, Robison LL, et al. Smoking in adult survivors of childhood acute lymphoblastic leukemia. J Natl Cancer Inst. 1998;90(3):219–25.PubMedCrossRef
22.
Boffetta P, Hecht S, Gray N, Gupta P, Straif K. Smokeless tobacco and cancer. lancet Oncol. 2008;9(7):667–75.PubMedCrossRef
23.
Rodu B, Jansson C. Smokeless tobacco and oral cancer: a review of the risks and determinants. Crit Rev Oral Biol Med. 2004;15(5):252.PubMedCrossRef
24.
Rodu B, Cole P. Smokeless tobacco use and cancer of the upper respiratory tract* 1. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93(5):511–5.PubMedCrossRef
25.
Boffetta P, Aagnes B, Weiderpass E, Andersen A. Smokeless tobacco use and risk of cancer of the pancreas and other organs. Int J Cancer. 2005;114(6):992–5.PubMedCrossRef
26.
Tyc VL, Hadley W, Crockett G. Prediction of health behaviors in pediatric cancer survivors. Med Pediatr Oncol. 2001;37(1):42–6.PubMedCrossRef
27.
Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, Maisonneuve P. Smoking and colorectal cancer. JAMA J Am Med Assoc. 2008;300(23):2765.CrossRef
28.
Johnson KC, Miller AB, Collishaw NE, Palmer JR, Hammond SK, Salmon AG, et al. Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009). Tob Control. 2011;20(1):e2.PubMedCrossRef
29.
Centers for Disease Control and Prevention. Public health surveillance for behavioral risk factors in a changing environment: recommendations from the Behavioral Risk Factor Surveillance Team. MMWR Morb Mortal Wkly Rep. 2003;52:1–12.
30.
Gentry EM, Kalsbeek WD, Hogelin GC, Jones JT, Gaines KL, Forman MR, et al. The behavioral risk factor surveys: II. Design, methods, and estimates from combined state data. Am J Prev Med. 1985;1(6):9–14.PubMed
31.
Behavioral Risk Factor Surveillance System: 2009 Summary Data Quality Report [Internet].
32.
33.
34.
Centers for Disease Control and Prevention. Current trends smoking prevalence and cessation in selected States, 1981–1983 and 1985—The Behavioral Risk Factor Surveys. MMWR Morb Mortal Wkly Rep. 1986;35(47):740–3.
35.
Mariotto AB, Rowland JH, Ries LA, Scoppa S, Feuer EJ. Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomarkers Prev. 2007;16(3):566–71.PubMedCrossRef
36.
Browman GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med. 1993;328(3):159–63.PubMedCrossRef
37.
Gritz ER, Dresler C, Sarna L. Smoking, the missing drug interaction in clinical trials: ignoring the obvious. Cancer Epidemiol Biomarkers Prev. 2005;14(10):2287–93.PubMedCrossRef
38.
Ebbert JO, Williams BA, Sun Z, Aubry MC, Wampfler JA, Garces YI, et al. Duration of smoking abstinence as a predictor for non-small-cell lung cancer survival in women. Lung Cancer. 2005;47(2):165–72.PubMedCrossRef
39.
40.
Bellizzi KM, Rowland JH, Jeffery DD, McNeel T. Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol. 2005;23(34):8884–93.PubMedCrossRef
41.
Centers for Disease Control and Prevention (CDC). Vital signs: current cigarette smoking among adults aged >/=18 years—United States, 2005–2010. MMWR Morb Mortal Wkly Rep. 2011;60(35):1207–12.
42.
Jha P, Ranson MK, Nguyen SN, Yach D. Estimates of global and regional smoking prevalence in 1995, by age and sex. Am J Public Health. 2002;92(6):1002–6.PubMedCrossRef
43.
44.
Castellsague X, Munoz N. Chapter 3: Cofactors in human papillomavirus carcinogenesis—role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr. 2003;31:20–8.PubMedCrossRef
45.
Chaturvedi AK, Engels EA, Gilbert ES, Chen BE, Storm H, Lynch CF, et al. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst. 2007;99(21):1634–43.PubMedCrossRef
46.
Coker AL, DeSimone CP, Eggleston KS, Hopenhayn C, Nee J, Tucker T. Smoking and survival among Kentucky women diagnosed with invasive cervical cancer: 1995–2005. Gynecol Oncol. 2009;112(2):365–9.PubMedCrossRef
47.
Flint AJ, Novotny TE. Poverty status and cigarette smoking prevalence and cessation in the United States, 1983–1993: the independent risk of being poor. Tob Control. 1997;6(1):14–8.PubMedCrossRef
48.
Zhu BP, Giovino GA, Mowery PD, Eriksen MP. The relationship between cigarette smoking and education revisited: implications for categorizing persons' educational status. Am J Public Health. 1996;86(11):1582–9.PubMedCrossRef
49.
Doescher MP, Jackson JE, Jerant A, Gary Hart L. Prevalence and trends in smoking: a national rural study. J Rural Health. 2006;22(2):112–8.PubMedCrossRef
50.
Parikh S, Brennan P, Boffetta P. Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer. 2003;105(5):687–91.PubMedCrossRef
51.
Singh GK, Miller BA, Hankey BF, Edwards BK. Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975–2000. Cancer. 2004;101(5):1051–7.PubMedCrossRef
52.
Benard VB, Coughlin SS, Thompson T, Richardson LC. Cervical cancer incidence in the United States by area of residence, 1998–2001. Obstet Gynecol. 2007;110(3):681–6.PubMedCrossRef
53.
Fiore M. Treating tobacco use and dependence: 2008 update: clinical practice guideline. Darby: DIANE Publishing; 2008.
54.
Gritz ER, Fingeret MC, Vidrine DJ, Lazev AB, Mehta NV, Reece GP. Successes and failures of the teachable moment. Cancer. 2006;106(1):17–27.PubMedCrossRef
55.
Coups EJ, Dhingra LK, Heckman CJ, Manne SL. Receipt of provider advice for smoking cessation and use of smoking cessation treatments among cancer survivors. J Gen Intern Med. 2009;24 Suppl 2:S480–6.PubMedCrossRef
56.
Emmons K, Li FP, Whitton J, Mertens AC, Hutchinson R, Diller L, et al. Predictors of smoking initiation and cessation among childhood cancer survivors: a report from the childhood cancer survivor study. J Clin Oncol. 2002;20(6):1608.PubMedCrossRef
57.
Nathan PC, Ford JS, Henderson TO, Hudson MM, Emmons KM, Casillas JN, et al. Health behaviors, medical care, and interventions to promote healthy living in the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009;27(14):2363.PubMedCrossRef
58.
Fiore MC, Novotny TE, Pierce JP, Giovino GA, Hatziandreu EJ, Newcomb PA, et al. Methods used to quit smoking in the United States. JAMA J Am Med Assoc. 1990;263(20):2760.CrossRef
59.
60.
Desai MM, Bruce ML, Desai RA, Druss BG. Validity of self-reported cancer history: a comparison of health interview data and cancer registry records. Am J Epidemiol. 2001;153(3):299–306.PubMedCrossRef
61.
Hewitt M, Breen N, Devesa S. Cancer prevalence and survivorship issues: analyses of the 1992 National Health Interview Survey. J Natl Cancer Inst. 1999;91(17):1480–6.PubMedCrossRef
62.
Blumberg SJ, Luke JV. Wireless substitution: early release of estimates from the National Health Interview Survey, July–December 2007. 2008.
63.
Nelson DE, Powell-Griner E, Town M, Kovar MG. A comparison of national estimates from the National Health Interview Survey and the Behavioral Risk Factor Surveillance System. Am J Public Health. 2003;93(8):1335–41.PubMedCrossRef
64.
Emmons KM, Puleo E, Park E, Gritz ER, Butterfield RM, Weeks JC, et al. Peer-delivered smoking counseling for childhood cancer survivors increases rate of cessation: the partnership for health study. J Clin Oncol. 2005;23(27):6516.PubMedCrossRef
65.
Graubard BI, Korn EL. Predictive margins with survey data. Biom. 1999;55(2):652–9.
66.
Emmons K, Li FP, Whitton J, Mertens AC, Hutchinson R, Diller L, et al. Predictors of smoking initiation and cessation among childhood cancer survivors: a report from the childhood cancer survivor study [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. J Clin Oncol. 2002;20(6):1608–16.PubMedCrossRef
67.
Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review]. J Clin Oncol. 2005;23(24):5814–30.PubMedCrossRef
68.
Centers for Disease Control and Prevention, et al. Surveillance of demographic characteristics and health behaviors among adult cancer survivors—Behavioral Risk Factor Surveillance System, United States, 2009. MMWR Morb Mortal Wkly Rep. 2012;61(1):1–23.
69.
Gritz ER, Nisenbaum R, Elashoff RE, Holmes EC. Smoking behavior following diagnosis in patients with stage I non-small cell lung cancer [Research Support, U.S. Gov't, P.H.S.]. Cancer Causes Control. 1991;2(2):105–12.PubMedCrossRef
70.
Underwood JM, Rim SH, Fairley TL, Tai E, Stewart SL. Cervical cancer survivors at increased risk of subsequent tobacco-related malignancies, United States 1992–2008. Cancer Causes Control. 2012;(in press)
71.
Metadata
Title
Persistent cigarette smoking and other tobacco use after a tobacco-related cancer diagnosis
Authors
J. Michael Underwood
Julie S. Townsend
Eric Tai
Arica White
Shane P. Davis
Temeika L. Fairley
Publication date
01-09-2012
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 3/2012
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-012-0230-1

Other articles of this Issue 3/2012

Journal of Cancer Survivorship 3/2012 Go to the issue

OriginalPaper

Disease self-management needs of adolescents with cancer: perspectives of adolescents with cancer and their parents and healthcare providers

OriginalPaper

Childhood Cancer Survivor Study participants’ perceptions and knowledge of health insurance coverage: implications for the Affordable Care Act

OriginalPaper

Cancer perceptions: implications from the 2007 Health Information National Trends Survey

OriginalPaper

A cohort study of permanently reduced work ability in breast cancer patients

OriginalPaper

Fostering partnerships in survivorship care: report of the 2011 Canadian genitourinary cancers survivorship conference

OriginalPaper

Unmet adolescent and young adult cancer survivors information and service needs: a population-based cancer registry study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits